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Controversy over the frequency of human B1 cells in normal individuals has arisen as dif-
ferent labs have begun to employ non-uniform techniques to study this population. The
phenotypic proﬁle and relative paucity of circulating human B1 cells place constraints on
methodology to identify and isolate this population. Multiple steps must be optimized to
insure accurate enumeration and optimal puriﬁcation. In the course of working with human
B1 cells we have developed a successful strategy that provides consistent analysis of B1
cells for frequency determination and efﬁcient isolation of B1 cells for functional studies.
Here we discuss issues attendant to identifying human B1 cells and outline a carefully
optimized approach that leads to uniform and reproducible data.
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INTRODUCTION
B1 cells constitute a distinct B cell lineage with a unique set
of characteristics that includes constitutive production of nat-
ural antibody that is protective against microbial pathogens and
that assists in the disposition of cellular debris. This antibody is
broadly reactive, autoreactive, and repertoire skewed (Holodick
et al., 2009a; Yoshikawa et al., 2009; Zhong et al., 2009; Baumgarth,
2011). In addition, B1 cells efﬁciently present antigen and strongly
stimulate T cells via CD80/86 (Zhong et al., 2007), but are also
capable of immunosuppression due, at least in part, to production
of IL-10 (O’Garra et al., 1992; Popi et al., 2008; Lee et al., 2009b).
Some or all of these activities may relate to continual signaling
that is experienced by B1 cells (Holodick et al., 2009b). In model
systems the number and/or function of B1 cells have been con-
nected to autoimmune disease, cardiovascular disease, and other
dyscrasias (Murakami et al., 1995; Iizuka et al., 1998; Peterson et al.,
2008; Kyaw et al., 2011) Thus, B1 cells are involved in maintaining
microbial defense and immune homeostasis, and dysfunction of
B1 cells is associated with systemic illness. This has led to intense
interest in the physiological and clinical roles of B1 cells, which,
however, have been difﬁcult to evaluate because clear markers for
the human B1 cell population have been lacking for many years.
Early efforts to identify humanB1 cells usingCD5 expression com-
bined with expression of a B cell speciﬁc antigen, as in the murine
system, have not been revealing because CD5 is expressed on mul-
tiple human B cell populations including activated, pre-naïve, and
transitional B cells (Freedman et al., 1989; Sims et al., 2005; Lee
et al., 2009a; Grifﬁn et al., 2011a).
To elucidate markers that would better identify human B1 cells,
functional criteria were established based on murine studies and
then human B cells that fulﬁll those criteria were sought. Thus,
human B cells that spontaneously secrete immunoglobulin, evi-
dence tonic intracellular signaling, and efﬁciently stimulate T cells
were targeted. Ultimately, a previously unrecognized population
of CD20+ B cells within the CD27+ compartment, that is dis-
tinguished from memory B cells by expression of CD43, was
identiﬁed (Grifﬁn et al., 2011a). Beyond the qualifying charac-
teristics noted above, human B1 cells further parallel mouse B1
cells in generating anti-DNA and anti-phosphorylcholine (PC)
speciﬁcities, and in expressing a skewed variable heavy chain
(VH) repertoire (Silverman et al., 2000; Zhong et al., 2009; Grif-
ﬁn et al., 2011a). The discovery of a phenotypic “address” for
human B1 cells that is found within the CD27+ population, for-
merly considered to represent memory B cells, has fueled interest
in human B1 cells from two different angles: to isolate human
B1 cells for physiological and pathological examination; and, to
remove human B1 cells to improve study of CD27+CD43− true
memory B cells. However, a number of issues complicate efforts
to recognize human B1 cells. The absence of a reference stan-
dard, or standard protocol, for study of human B1 cells has
led to controversy concerning the actual frequency of human
B1 cells in normal individuals (Grifﬁn et al., 2011b). Successful
approaches to optimize work with human B1 cells are discussed
below.
MATERIALS AND METHODS
DONORS AND SAMPLES
Adult peripheral blood samples were obtained by venipuncture of
adult volunteers after obtaining informed consent in accordance
with the Declaration of Helsinki. Additional samples in the form
of leukopacks were obtained from the New York Blood Center on
the day of donation. This study was approved by, and all samples
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were obtained in accordance with, the Institutional Review Board
of the North Shore-LIJ Health System.
BLOOD SAMPLE PROCESSING
All blood samples were treated in a similar manner and processed
promptly upon receipt, except where the experimental design dic-
tated otherwise. Peripheral blood and leukopack samples were ini-
tially dilutedwithRPMI1640medium(Cellgro) 1:1.Mononuclear
cells were then obtained by density gradient centrifugation using
lymphocyte separation medium (Cellgro) at 1,500× g for 20min
at room temperature with no brake. The separated mononuclear
cells were recovered from the buffy coat interface and resuspended
in RPMI 1640. Mononuclear cells were then washed once with
RPMI 1640 medium and pelleted by centrifugation at 500× g for
15min at room temperature with the brake on. Cells were resus-
pended in RPMI 1640 supplemented only with 10% FCS after
which cell number and viability were determined with an auto-
mated cell counter (Digital Bio ADAM) after propidium iodide
staining. For assays requiring prolonged culture, cells were resus-
pended in RPMI 1640 containing 10% fetal calf serum plus 2mM
l-glutamine, 10mM HEPES (pH 7.25), 100U/ml penicillin and
100μg/ml streptomycin (without 2-ME).
B CELL ENRICHMENT
For some experiments B cells were enriched by CD19 positive
selection using the EasySep Human CD19+ B cell magnetic bead
selection kit (StemCell Technologies) according to the manufac-
turer’s instructions. For some experiments B cells were enriched
by CD20 positive selection using the EasySep Human CD20+ B
cell magnetic bead selection kit (StemCell Technologies).
CELL SORTING AND FLOW CYTOMETRIC ANALYSIS
Cells were stained using a master mix of antibodies to maintain
consistency among the samples. Cells for analysis and sorting
were blocked with, and then stained in, dye-free RPMI 1640
supplemented with 10% FCS. For analysis, immunoﬂuorescently
stained cells suspended at 1 million/ml were examined at a ﬂow
rate of 1,000 cellular events per second or less on a BD Bio-
sciences LSR-II and/or aBeckman-CoulterGallios cytometer. Cells
were vortexed brieﬂy (1–2 s) directly before analysis. Doublet fre-
quency was monitored during analysis in real time and stained
cells were vortexed again if doublet frequency exceeded 2% or
CD3+CD20+ events in the viable cell gate exceeded 1%. For sort
puriﬁcation, immunoﬂuorescently stained cells (CD19 enriched
B cells or PBMC) were suspended at a concentration below 10
million cells/ml in dye-free RPMI 1640/10% FCS supplemented
with 2mM EDTA and separated on an Inﬂux instrument (BD
Biosciences) at a ﬂow rate not exceeding 5,000 cellular events
per second unless otherwise noted, and a sheath core differen-
tial of 2 psi or less. Stained cells were periodically vortexed for 2 s
and at times when ﬂow rates dropped by greater than 20% or cells
sedimented in sample tubes.
CELL FREEZING, THAWING, AND FIXING
Cells (100 million or less) were pelleted and gently resuspended
in 1ml freezing solution containing 90% FCS and 10% DMSO at
room temperature. Cells were quickly transferred to 2ml cryovials
and cooled by placement of these vials in freezing containers (Mr
Frosty) in a−80˚C freezer for aminimumof 48 h before transfer to
liquidnitrogen for prolonged storage at−160˚C.Cellswere thawed
bywarming frozen vials in a 37˚Cwater bath until icewas no longer
visible, after which 1ml of pre-warmed RPMI 1640 without sup-
plementation was added to the now thawed cells in the cryovial.
Cells were gently mixed to avoid excessive shear forces and trans-
ferred drop wise into 9ml pre-warmed RPMI 1640. Cells were
then pelleted and washed once with RPMI 1640 supplemented
with 10% FCS. When necessary, cells were ﬁxed by suspending
them in 1.6% paraformaldehyde for 15min at room temperature
and were then washed and resuspended in PBS.
REAGENTS
Fluorescently labeled mouse antibodies (anti-CD20-V450
cat#642274 clone L27 IgG1κ, anti-CD27-APC cat#337169 clone
L128 IgG1κ, anti-CD43-FITC cat#555475 clone 1G10 IgG1κ,
and anti-CD3-PE cat#555333 clone UCHT1 IgG1κ, V450-Isotype
control cat#560373 clone MOPC-21 IgG1κ, APC-Isotype con-
trol cat#555751 clone MOPC-21 IgG1κ FITC-Isotype control
cat#555748 clone MOPC-21 IgG1κ, and PE-Isotype control
cat#340761 clone X40 isotype IgG1 κ), were obtained from BD
Biosciences.
RESULTS
OVERVIEW
B1 cells represent a small subset residing within a dominant B cell
population, as a result of which the ability to distinguish B1 cells
from other lymphocytes is dependent on key parameters includ-
ing: the selection, quality, and efﬁciency of immunoﬂuorescent
staining; the sensitivity and speciﬁcity of ﬂuorescence excitation
and detection; the speciﬁc application and hierarchy of gating
strategies; and, the competency of computerized algorithms for
cytometric data interpretation. Moreover, the phenotypic nature
of human B1 cells, encompassing expression of CD20, CD27,
and CD43, imposes certain limitations on methodology to iden-
tify and isolate this population; in particular, CD27 and CD43
expression is shared by most peripheral blood T cells, whose num-
bers far outweigh the number of B cells, so that B (CD20+)-T
(CD27+CD43+) doublets could be mistaken for B1 cells. These
and other issues discussed below dictate the need for careful
review of technical considerations to optimize identiﬁcation and
recovery. Recommended procedures are discussed below in more
or less chronological order leading from initial blood sample to
analyzed/sorted B1 cell preparation.
INITIAL CELL HANDLING
The most accessible B1 cell-containing human tissue is blood,
and typical samples arrive either as newly drawn adult peripheral
blood, as recently processed adult blood leukopacks, or as freshly
obtained umbilical cord blood. Access to the ﬁrst is measured
in minutes, whereas access to the latter two samples is typically
measured in hours. In general, the more immediate the sample,
the better the B1 cell recovery. From each of the sources noted
above peripheral blood mononuclear cells (PBMC) are obtained
by density gradient centrifugation after dilution as described in
“Materials and Methods.” Although heparin is typically used for
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anticoagulation of newly drawn peripheral blood, some samples,
such as leukopacks and umbilical cord blood samples, may rely
on citrate anticoagulation which can be reversed with calcium-
containing buffers, such as Hank’s balanced salt solution. This may
lead to clot formation interfering with subsequent steps. Thus,
dilution of citrate-containing samples with medium or buffer
containing no calcium (e.g., PBS) is preferred.
Tissue samples such as spleen, tonsil, or lymph node are likely
to become available with typically longer delays than noted above,
such that changes occurring due to loss of viability prior to acquisi-
tion may be an issue. Analysis of such specimens is likely to beneﬁt
from viability staining to eliminate dead and dying cells. Viability
staining may also be appropriate with blood samples if/when dete-
rioration is suspected; however, it should be noted that annexin V
staining is not suitable for recognizing apoptotic B1 cells (Dillon
et al., 2001).
IMMUNOFLUORESCENT STAINING AND B1 CELL RECOGNITION
Optimization of staining parameters facilitates recognition of
human B1 cells. Mature B cells typically express both CD19 and
CD20. Of note, however, as B cells differentiate to become plas-
mablasts and plasma cells, CD20 is lost but CD19 remains, as
CD38/CD138 is acquired (Jego, 2001). Thus, in terms of anti-
body selection for immunoﬂuorescent staining of B cells, iden-
tiﬁcation with anti-CD20 rather than anti-CD19 is preferred, in
order to avoid those B cells that are committed to plasmacytic
differentiation (Table 1).
Because expression by T cells of both CD27 and CD43 could
complicate analysis of B1 cells as a result of B:T doublet for-
mation (see below), anti-CD3 is added to exclude T cells from
consideration, as displayed in the typical gating strategy for B1 cell
identiﬁcation shown in Figure 1. Although rare CD20+ B cells
that express CD3 have been reported to exist (Yokose et al., 2001;
Wang et al., 2009; Perez-Andres et al., 2011), normal B1 cells do not
express CD3 (Grifﬁn et al., 2011b). The addition of CD3-negative
gating also reduces concerns that positive staining for any marker
results from high autoﬂuorescence and/or non-speciﬁc binding
and is thus artifactual.
Among CD20+ B cells, B1 cells are recognized by expression of
CD27 and CD43. These markers coincide in umbilical cord blood
samples, as no memory B cells are present at birth, whereas in
adult peripheral blood, CD43 separates B1 cells from the CD27+
B cell population which contains both B1 cells and true memory B
Table 1 | Surface phenotype of major lymphocyte classes.
Cell subsets Surface phenotype
Naïve B cells CD3−CD19+CD20+CD27−CD43−CD69−CD70−
Memory B cells CD3−CD19+CD20+CD27+CD43−CD69−CD70−
B1 cells CD3−CD19+CD20+CD27+CD43+CD69−CD70−
Plasmablasts/plasma
cells
CD3−CD19lowCD20low/−CD27++CD43++CD138±
CD43+ activated B
cells
CD3−CD19+CD20+CD27±CD43+CD69++CD70++
T cells CD3+CD19−CD20−CD27±CD43±
cells (Grifﬁn et al., 2011a). Notably, CD43 expression on B1 cells is
lower than CD43 expression on T cells (or activated B2 cells). For
this reason successful identiﬁcation of B1 cells depends on the use
of anti-CD43 antibody-ﬂuorophore conjugates with high signal-
to-noise ratios, such as FITC, PE, or APC, and suitably sensitive
ﬂuorophore detection (see below). The larger the gulf between
positive and negative B cells, particularly with respect to CD43,
the more readily B1 cells can be distinguished from other B cell
types and the more reliably frequency values can be determined
(Figures 2A and 3). The ability to more clearly demarcate CD43+
B1 cells facilitates further phenotypic-functional characterization
of this population as we have done using CD11b (Grifﬁn and
Rothstein, 2011; Grifﬁn et al., 2012).
The signal-to-noise ratio of antibody-ﬂuorophore conjugates
is only apparent following excitation and detection and thus
instrument characteristics play a key role in determining the efﬁ-
ciency with which B1 cells are recognized. These features include
laser intensity and stability; ﬁberoptic path length; ﬁlter number,
bandwidth and efﬁciency; ﬂuorescence detector sensitivity; and,
coincident rejection rate; among others, all of which are beyond
the scope of the present discussion. In aggregate, instrument vari-
ables alone can greatly affect recognition and enumeration of B1
cells.When the exact same immunoﬂuorescently stained and ﬁxed
PBMC were evaluated on two different ﬂow cytometers, CD43
expression by CD20+CD27+ B cells was more cleanly distin-
guished on one instrument (Gallios) than the other (LSR-II), as
illustrated by contour display of the gated CD20+CD27+CD43+
B1 cells on the CD27 by CD43 plot (Figure 2A). This then pro-
duced a perceived difference in B1 cell frequency, which was
erroneously low when CD43 separation was poor (Figure 2B)
because of population overlap and gating issues resulting there
from (see below).
Existing machines can be optimized for visualization of anti-
gens expressed at low levels. Replacement of the standard bandpass
ﬁlters by ﬁlters with broader rangeswill result in collection of more
emitted light. This will result in improved frequency determina-
tions for human B1 cells on the same instrument, dependent on
the degree of optimization for detection of poorly expressedmark-
ers such as CD43. Adjusting the photomultiplier (pmt) voltage
to achieve the greatest separation between positive and nega-
tive populations rather than arbitrary placement of the negative
population in the ﬁrst decade should also be considered.
GATING AND B1 CELL ENUMERATION
The ultimate arbiter of frequency for, and/or isolation of, any
phenotypically identiﬁed population lies in the way in which gat-
ing structures and boundaries are applied to ﬂuorescence images
thereby deﬁning the cells of interest. Where populations overlap,
slight changes in the location of the cutoff between positive and
negative cells will greatly inﬂuence measured frequencies. This is
exempliﬁed by CD43 staining, discussed above, and is illustrated
conceptually in Figure 3A. Setting a line that distinguishes CD43+
fromCD43− Bcells that expressCD27 is simplewhen the antibody,
ﬂuorophore, and instrument yield clear separation between B cells
that do and do not express CD43. However, when low expression
or low detection result in overlap between the contours of CD43-
expressing and non-expressing B cells, gating placement becomes
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FIGURE 1 | Human B1 cells are identified by immunofluorescent
staining and analysis of peripheral blood mononuclear cells. Adult
peripheral blood mononuclear cells PBMC) were immunoﬂuorescently
stained for CD20(V450), CD27(APC), CD43(FITC), and CD3(PE), and were
then evaluated by ﬂow cytometric analysis on a BD LSR-II. The gating
strategy used to separate CD3−CD20+CD27−CD43− (naive B cells),
CD3−CD20+CD27+CD43− (memory B cells), and
CD3−CD20+CD27+CD43+ (B1 cells) for a typical adult blood sample is
shown along with the FMO controls that were used to determine the
gates for CD27 and CD43 positivity.
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FIGURE 2 | Different flow cytometers are more or less effective in
distinguishing CD43+ B1 cells leading to different frequency
determinations. (A,B) Adult peripheral blood mononuclear cells were
immunoﬂuorescently stained for CD20, CD27, CD43, and CD3, were ﬁxed
and were then evaluated by ﬂow cytometric analysis. (A) Expression of CD27
and CD43 by the same CD3-CD20+ singlet gated cells is shown as a dot plot
for 2 different ﬂow cytometers. Mapping of CD3−CD20+CD27+CD43+ (B1)
cells is shown as a contour plot for each of two different ﬂow cytometers.
(B) Frequency determinations for the same ﬁxed CD3−CD20+CD27+CD43+
(B1) cells analyzed on a BD LSR-II ﬂow cytometer and a Beckman-Coulter
Gallios ﬂow cytometer are shown in the top plot, along with lines indicating
mean values and standard errors of the means (n=30), while the same
values for B1 cell frequencies are shown in the bottom plot along with
connector lines identifying the same sample on each machine.
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both more difﬁcult and more critical to the numbers generated.
Note that line setting to distinguish positive and negative stain-
ing is critical to enumerate members of a population, the goal of
which is accurate determination of cell composition. In contrast,
cell sorting for population isolation strives formaximumpurity, so
that collection gates typically omit a region in between markedly
positive and clearly negative (Grifﬁn et al., 2011b; Figure 3C).
A further illustration of CD43 discrimination at a single CD27
intensity is displayed in histogram plots of relative cell number vs
CD43 expression for duplicate samples analyzed on theGallios and
LSR-II cytometers (Figure 3B). When machine (or staining) char-
acteristics fail to provide a clear separation between positive and
negative expression (see LSR-II),positive values (i.e., blue idealized
tracing) blend with negative values (i.e., orange idealized tracing)
such that any cutoff for CD43 positivity will, of necessity, include
CD43 negative cells that don’t belong or omit CD43 positive cells
that do belong, or both. In contrast, clear separation between pos-
itive and negative expression (see Gallios) markedly improves the
ease, reproducibility, and validity with which a positive cutoff can
be chosen.
Several methods have been advocated for delineating gate-
setting that separates positive and negative staining values when
clear separation is not achievable, with most focusing on generic
approaches consisting of either no-staining controls, irrelevant-
antibody-isotype-matched controls, and ﬂuorescence-minus-one
(FMO) controls (Perfetto et al., 2004; Maecker and Trotter, 2006).
The choice and use of these controls can have a signiﬁcant impact
on determination of B1 cell frequencies. With respect to CD43+
B1 cells, no-stain controls often underestimate the cutoff between
positive and negative populations, while use of either isotype-
matched controls or FMO controls result in very similar cutoffs
between positive and negative values (Perfetto et al., 2004). FMO
works to control for ﬂuorescence signals in the CD43 channel due
to staining with other antibody-ﬂuorophore conjugates; isotype
control staining (that matches the CD43 isotype) works to con-
trol for non-speciﬁc and/or FcR binding. A typical protocol sets
quadrant thresholds such that less than 1% of control events are
positive for any single stain. It should be recognized that despite
these aids, application of any linear distinction to overlapping dis-
tributions will in all likelihood lead to erroneous enumeration of
the B1 cell population, as noted above. This general problem may
be addressed computationally by determining for normal distrib-
utions the extent to which one contour/population extends within
another using gaussian sums or non-linear least squares analysis.
The highest level of accuracy for calculating this overlap may be
through the use of models such as the Watson Pragmatic or the
Dean-Jett-Fox, as has been done for calculation of cell cycle stage
(Fox, 1980; Watson et al., 1987). However, the best solution to this
problem lies in approaches that produce a clear gulf between those
cells that express CD43 and those that lack it by virtue of optimized
antibody, ﬂuorophore and instrument choices (Figure 2A).
AVOIDING DOUBLETS WHILE STILL INCLUDING B1 CELLS
Because T cells aremuchmore abundant thanB cells in the periph-
eral circulation, any stochastic tendency of B cells to adhere to
another lymphocyte will likely involve a B:T combination. It is
not clear however that all doublets result from purely stochastic
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FIGURE 3 | Gating to distinguish positively and negatively stained B
cells is difficult when populations overlap. (A) Diagrammatic models of
ideal separation vs overlapping detection of CD43+ and CD43− populations
of CD27+ B cells are shown. (B) Adult peripheral blood mononuclear cells
were immunoﬂuorescently stained for CD20, CD27, CD43, and CD3, and
were then evaluated by ﬂow cytometric analysis. Expression of CD43 on
CD3−CD20+CD27+ cells as detected by a BD LSR-II ﬂow cytometer and a
Beckman-Coulter Gallios ﬂow cytometer on the same representative adult
peripheral blood sample is displayed as a histogram along with idealized
normal distribution curves. (C) Diagrammatic models of sorting gates
applied to ideal separation vs overlapping detection of cell populations are
shown.
processes so the actual rather than predicted types of doublets
involving B cells may vary for different B cell subpopulations.
Because most T cells express CD27 and CD43, any B:T dou-
blet is likely to phenotype as CD20+ (contributed by the B cell
constituent), and CD27+CD43+ (contributed by the T cell con-
stituent; Figure 4). Thus, it is important to employ means to avoid
and/or eliminate doublets in order to avoid enumeration of naive
B:T doublets and memory B:T doublets as B1 cells resulting in
artifactual inﬂation of B1 cell frequencies.
Modern ﬂow cytometer software incorporates algorithms that
make it possible to detect and reject doublets and coincident
events, based on area vs height or pulse-width considerations,
thereby eliminating events that fall outside typical parameters for
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T-cell B-cell doubletB1-cell singlet
FIGURE 4 | B:T doublets can masquerade as CD20+CD27+CD43+ B1
cells. A diagrammatic model for the phenotypic readout of B:T doublets is
shown.
the size and roundness of single cells. There are three reasons
why this approach can be problematical. (1) Two cells may line
up one behind the other with respect to the light path so that a
doublet masquerades as having a normal area/height conﬁgura-
tion and fails to be rejected, leading to inadvertent overcounting;
(2) Rejection of large numbers of cells presented for analysis
may entail omission of many cells of interest that are tied up in
doublets, leading to inadvertent undercounting; and, (3) Doublet
discrimination parameters used to separate normal spherical cell
shapes and sizes from outliers are essentially arbitrary and can-
not incorporate perfect sensitivity and speciﬁcity and thus may
omit unusually large or irregularly shaped cells (Bauer, 1993;Wer-
sto et al., 2001). For these reasons the best and most accurate
approach is to avoid or reverse doublet formation before B1 cell
analysis and/or isolation, rather than rely on after-the-fact dou-
blet discrimination (Bauer, 1993). Several simple steps markedly
reduce the number of doublets contained within interrogated
samples. These include dilution of cell suspensions to less than
1 million cells/ml and brief vortexing of samples just prior to
analysis. The relationship between these parameters and doublet
frequencies is shown elsewhere (Grifﬁn et al., 2011b). Notably,
excessive vortexing itself can lead to doublet formation so no
more than 1–2 s is recommended. In addition, cytometer run
speeds of 1,000 cellular events per second or less reduce coinci-
dent events and help to insure that only single events are evaluated.
Although doublet formation should be negligible with these pre-
cautions, CD3-negative gating will exclude any remaining B:T
doublets.
Following CD3-negative gating all the CD20+CD27+CD43+
events should correspond to B1 cells as naïve and memory B cells
are negative for CD43 expression and consequently would not fall
into this gate. However, it is conceivable that memory B cells might
form doublets with activated B cells or with myeloid/monocyte
cells, in each case producing CD20+CD27+CD43+ events. Dou-
blet discrimination can then be used as a supplementary means of
excluding doublets that may have persisted through the prepara-
tory steps discussed above. When employing pulse-gating meth-
ods for doublet or aggregate discrimination, gating should be
based on clearly deﬁned singlet vs doublet populations to avoid
arbitrary exclusion of singlet cells with larger size and/or lower
sphericality. Since most doublet discrimination relies on the
relationship between size and either area or width a perfectly
round cell will fall in the center of a histogram or contour
visualization of singlet cells. There will be a certain width to
the histogram or contour visualization of single cells based on
the mathematical principle of probabilistic aggregation forma-
tion, whereby events of a given population cluster about a mean
value with a slight degree of random variation that results in a
bell shaped curve (Sharpless and Melamed, 1976; Wersto et al.,
2001). In examining cells, a portion of which have a slightly larger
and/or less round shape, there should be an expected skew to
the right for the single cell histogram with a disproportionate
number of B1 cells to the right of the mean (Figures 5A,B).
Despite this skew, doublet cells should be visible as a distinct and
separate population, especially when their number is increased
by intentional gating on CD3+CD20+ events. This, then, can
provide information regarding the proper placement of dou-
blet discrimination gates (Figures 5A,B). Because B1 cells are
in general larger and more irregular in shape than naïve B
cells (Grifﬁn and Rothstein, 2011; Grifﬁn et al., 2011b) aggres-
sive doublet discrimination as in gating that excludes the right
skew of the contour is likely to disproportionately exclude B1
cells from consideration and lead to erroneously low frequency
determinations.
The locations of singlet events and doublet events will be
clearly indicated even without gating on CD3+CD20+ events if
the interrogated sample contains a signiﬁcant number of dou-
blets. However, if samples are vortexed, and if CD3 exclusion is
employed, few, if any, doublets should be detected, as a result of
which B1 cell frequencies determined with and without doublet
discrimination should vary little (Figure 5C). For consistency, we
recommend following the gating strategy as outlined in Figure 1
which includes both doublet gating and CD3-negative gating.
Unfortunately there may be times when the situation is less
than optimal and cell preparations are not presented for analy-
sis as true single cell suspensions. In such circumstances doublet
discrimination can be used to computationally eliminate dou-
blets that will both improve the reliability of data analysis and
provide important information regarding the quality of the sam-
ple being analyzed. Thus, any signiﬁcant difference in B1 cell
frequency notedwith/without doublet discrimination,or the pres-
ence of a large number of detected CD3+CD20+ events, would
suggest improvements are needed in initial sample preparation to
counteract doublet formation and/or persistence.
The effectiveness of doublet avoidance can be measured in
several different ways. Monitoring DNA content after staining
with Hoechst 33342, enumeration of CD20+CD3+ events after
anti-CD3 staining, and determination of cells falling outside dou-
blet discrimination settings, can each provide information on the
relative abundance of singlet events that were evaluated and/or
sorted.
The goal of interrogating dilute cell suspensions at modest
events per second, to avoid doublets, is not always possible during
sort puriﬁcation of infrequent cell populations. In this situation
enrichment of B cells with anti-CD19-magnetic bead conjugates
substantially diminishes apparent B:T doublet formation (and in
this respect StemCell Technology conjugates appear to yieldhigher
post-enrichment B1 cell frequencies than Miltenyi products). In
addition, suspension of cells in 2mM EDTA counteracts doublet
formation.
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FIGURE 5 | Gating to eliminate doublets should not impinge on large or
irregularly shaped cells. Adult peripheral blood mononuclear cells were
immunoﬂuorescently stained for CD20, CD27, CD43, and CD3, and were then
evaluated by ﬂow cytometric analysis. Examples of doublet discrimination by
FSC-H/FSC-A [LSR-II instrument (A)] and FSC-W [Gallios instrument (B)] are
shown along with recommended gates. (C) Frequency determinations for
CD3−CD20+CD27+CD43+ B1 cells resulting from doublet discrimination vs no
doublet discrimination strategies after analysis on a Gallios ﬂow cytometer are
shown along with lines indicating mean values and standard errors of the
means (n=30).
OPTIMIZING B1 CELL IDENTIFICATION, RECOVERY, AND STUDY
The characteristics and behaviors of human B1 cells suggest addi-
tional means to enhance identiﬁcation and recovery. Although
most B1 cells fall within typical lymphocyte gating for size (FSC)
and granularity (SSC), some do not. For this reason a larger than
usual cell gate will include more B1 cells (Figure 1) At the same
time, more non-B cells will be captured requiring additional care
to select only B cells for evaluation.
As noted above, the rapidity with which blood samples are
processed following acquisition, the better the identiﬁcation and
isolation of B1 cells. The detection and/or recovery of B1 cells is
diminished by any postponement of sample processing, regardless
of condition. Samples retained overnight as heparinized whole
blood or as separated PMBC, at room temperature or at 4˚C, lose
B1 cells (Figure 6A) due at least in part to loss of detectable CD27
expression, so that CD20+CD27−CD43+ B cells are now found in
substantial numbers. B1 cell frequencies are successfully preserved
through either of two approaches for delayed analysis: (1) Freeze
cells and thaw when ready to immunoﬂuorescently stain, and then
analyze or sort; or (2) Fix immunoﬂuorescently stained cells for
later analysis (Figure 6B). In particular, appropriate freezing and
thawing procedures yield high post-thaw viability (Figure 6C)
and undiminished B1 cell frequencies (Figure 6B). Despite using
optimal techniques the frequency for human B1 cells is clearly
lower when leukopack samples are compared to freshly drawn
samples, which may be due either to the time delay in acquisi-
tion of leukopack samples, or to the nature of leukpack processing
prior to acquisition, or both (Figure 6D).
DISCUSSION
The peculiarities of human B1 cells – representing a small B cell
population that shares surface antigens with memory B cells, T
cells, and monocytes/macrophages – amplify any shortcomings in
standard approaches to immunoﬂuorescent staining and analy-
sis. Failure to optimize protocols can easily lead to erroneous
assignment and either undercounting or overcounting of B1 cell
numbers, with similarly detrimental implications for functional
studies of sort-puriﬁed B1 cell characteristics.
Because CD43 “carves out” B1 cells from among CD27+ B
cells that have been characterized as memory B cells, it is now
clear that much memory B cell work to date has been conducted
on heterogeneous populations that included “true” memory B
cells (CD27+CD43−) and B1 cells (CD27+CD43+). Some char-
acteristics of memory B cells, such as efﬁcient allogeneic T cell
stimulation, appear to belong speciﬁcally to B1 cells (Grifﬁn and
Rothstein, 2011; Grifﬁn et al., 2011a). Thus, it is critically impor-
tant to properly identify B1 cells not only to seek out the role and
function of B1 cells, but to properly evaluate the features of other
B cell types in the absence of “contamination” by included but
unrecognized B1 cells.
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FIGURE 6 | Peripheral blood samples should be analyzed immediately or
frozen or fixed for later analysis, and within these parameters fresh
samples are preferable to leukopack samples. (A) Adult peripheral blood
samples were processed immediately and then stained and analyzed
immediately (Fresh), stored as whole blood for 24 h at 4˚C before being
processed and then stained and analyzed (Blood at 4˚), or processed
immediately and stored as PBMC for 24 h at 4˚C before being stained and
analyzed (PBMC at 4˚). Three independent determinations of identiﬁed
CD3−CD20+CD27+CD43+ B1 cell frequencies are shown for the three
different approaches, along with lines indicating mean values and standard
errors of the means. (B) Adult peripheral blood samples were processed
immediately to PBMC and were then immunoﬂuorescently stained for CD20,
CD27, CD43, and CD3 and immediately analyzed (Fresh); or the samples were
processed immediately to PBMC, immunoﬂuorescently stained for CD20,
CD27, CD43, and CD3, and then ﬁxed for analysis the next day (Fixed); or the
samples were processed to PBMC, frozen for 48 h, thawed and then
immunoﬂuorescently stained for CD20, CD27, CD43, and CD3 and
immediately analyzed (Frozen). Determinations of identiﬁed
CD3−CD20+CD27+CD43+ B1 cell frequencies are shown for the three
different approaches, along with lines indicating mean values and standard
errors of the means (n=9). (C) Adult peripheral blood samples were
processed immediately to PBMC, which were then evaluated for viability after
staining with PI, or were frozen and then thawed, after which post-thaw
viability on total ungated cells was evaluated with PI staining using Digital Bio
ADAM, as per Methods. Individual determinations of cell viability (percent) are
shown along with lines indicating mean values (n=14). (D) Cells obtained
from leukopacks were processed immediately upon receipt, and blood
obtained from healthy donors was processed immediately post-phlebotomy
(Fresh samples), to obtain PBMC that were immunoﬂuorescently stained for
CD20, CD27, CD43, and CD3. Determinations of identiﬁed
CD3−CD20+CD27+CD43+ B1 cell frequencies are shown for the two
types of individual donors along with lines indicating mean values and
standard errors of the means (n=30 leukopack samples, n=27 healthy
donors).
Human B1 cells do not express CD3, for which reason CD3
expression can be used to monitor the frequency with which B:T
doublets have persisted and have become subject to analysis. Along
the same lines, CD3 expression can be used as an exclusionary cri-
terion to eliminate B:T doublets from consideration. However,
it is important to emphasize our general bias against exclusion-
ary criteria during identiﬁcation of new lymphocyte populations
lest B cells displaying unexpected surface antigens remain unrec-
ognized. This principle is well illustrated by the phenotype of
human B1 cells that includes determinants (e.g., CD27, CD43)
better known as characteristics of other immune cell populations
(Zhong et al., 2009; Grifﬁn and Rothstein, 2011; Grifﬁn et al.,
2011a). With human B1 cells, CD3 represents the exception rather
than the rule. Overall, we favor positive identiﬁcation and an ini-
tial approach that eschews the use of exclusionary criteria to assist
in identiﬁcation of speciﬁc B cell populations.
The relative loss of CD27 staining when PBMC processing is
delayed leads to a conundrum regarding gating strategy because
the topographical representation of CD27 then bridges the line
separatingCD27+ andCD27− B cells. This forces a choice between
including the entire CD43+ contour, encompassing portions that
are formally (by FMO) CD27−, or including just that portion
of the contour that is clearly CD27+. This, though, may be a
choice that need not be made. At the present time it appears
that no other B cells beyond B1 cells constitutively express CD43,
although naïve and memory B cells do so after activation. How-
ever, CD43-expressing activated naïve and memory B cells express
CD69 and CD70, whereas CD43− expressing B1 cells do not, as
noted elsewhere (Grifﬁn et al., 2011a). Thus, it may be that human
B1 cells can be adequately identiﬁed simply as CD20+CD43+
along with CD70−, although this remains to be veriﬁed under all
conditions.
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In our work to date we have documented extremely wide vari-
ation in the frequencies of B1 cells in the peripheral circulation
of normal volunteers. Whereas there is a general trend toward
fewer B1 cells in older individuals, at every age the range of
“normal” B1 cell frequencies may span less than 1% to greater
than 9% of circulating B cells. Some of these values may rep-
resent biological or statistical outliers, perhaps seemingly “nor-
mal” individuals who harbor an illness that is not yet apparent.
Alternatively, a large reservoir of B1 cells may exist somewhere
in the body (e.g., the peritoneal cavity, as in mice) such that
despite variations in circulating B1 cells, the total body num-
ber of B1 cells is similar from individual to individual and for
a given individual from time to time. Beyond these considera-
tions, it is always necessary to apply appropriate statistical analysis
before drawing conclusions that associate high or low frequencies
of B1 cells with any particular disease state or normal para-
meter to be sure that adequate numbers of samples have been
examined.
Summary of key approaches and recommendations:
1) Process biological samples urgently upon removal from the
individual; immediately freeze, or stain and ﬁx cells, if process-
ing delays are unavoidable.
2) Utilize high afﬁnity, high speciﬁcity antibodies for CD43 cou-
pled to ﬂuorophores with high signal-to-noise ratios (e.g.,
FITC, PE, APC) and analyze on a ﬂow cytometer with optimal
ﬁlters and high sensitivity.
3) Apply FMO controls in multiparametric analysis to set
population-deﬁning gates in the absence of clear separation
between populations. It is possible to use isotype controls in
setting gates, if four or fewer ﬂuorophores are employed (con-
sistently apply the chosen approach across all samples in a given
experiment).
4) Prepare samples at appropriate concentrations for analysis (1
million cells/ml or less) and agitate to prevent/reverse doublet
formation. Use EDTA (2mM) during sort puriﬁcation.
Acquire samples at rates that do not increase coincident events,
such as 1,000 cellular events/s. Use inclusive cell gatingwhereby
all cells are included and do not focus on a preconceived gate
for lymphocytes.
5) Employ CD3 exclusion in the gating hierarchy to avoid B:T cell
doublets, but do not use additional negative gating until it is
proven appropriate to do so with the same degree of rigor used
to establish CD3 as a negative gating marker.
6) Rely on doublet discrimination sparingly, keeping in mind that
although it can counteract poor sample preparation and inher-
ent cell–cell attraction, its use is accompanied by substantial
collateral effects.
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